Aprotinin revisited
Intensive Care Med
.
2014 Jan;40(1):142.
doi: 10.1007/s00134-013-3130-6.
Epub 2013 Oct 24.
Authors
Stacia M DeSantis
1
,
Christos Lazaridis
Affiliation
1
Division of Biostatistics, School of Public Health, University of Texas Health Science Center, 1200 Herman Pressler Street, RAS E809, Houston, TX, 77030, USA,
[email protected]
.
PMID:
24154674
PMCID:
PMC5038918
DOI:
10.1007/s00134-013-3130-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Aprotinin / adverse effects*
Aprotinin / therapeutic use*
Cardiac Surgical Procedures / adverse effects*
Female
Hemostatics / adverse effects*
Hemostatics / therapeutic use*
Hospital Mortality / trends*
Humans
Male
Substances
Hemostatics
Aprotinin
Grants and funding
M01 RR001070/RR/NCRR NIH HHS/United States